Drug discovery is a complex process that involves various scientific disciplines such as biology, chemistry, and pharmacology. In a recent study, Zhang and colleagues showcase the potential of using engineered smart probiotics in combination with a pill-camera-style endoscope for disease monitoring and therapeutic delivery in the gut. Additionally, positive results from a first-in-human clinical trial highlight the ANGPTL3–ANGPTL8 complex as a promising therapeutic target for reducing triglycerides and potentially lowering the risk of cardiovascular disease. The field of drug delivery is rapidly evolving with advances in implantable and ingestible devices, moving towards personalized and precise medicine. Furthermore, PROTACs, a novel therapeutic approach that facilitates the degradation of target proteins through E3 ligase enzymes, show great promise. This study delves into recent advancements and challenges in cereblon-based PROTACs, offering valuable insights for future development in targeted protein degradation. Another significant finding is the identification of napabucasin as a potential candidate for combatting refractory Helicobacter pylori infections, showcasing efficacy in murine infection models and elucidating its mechanism of action. Innovative approaches like high-throughput molecular dynamics simulations are essential for streamlining the drug discovery process by identifying potential inhibitors efficiently. This active learning framework presented by the authors sheds light on novel strategies for therapeutic applications.
Read more from nature.com